These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 8547539)
1. Exogenous hormone use and the risk of postmenopausal breast cancer: results from The Netherlands Cohort Study. Schuurman AG; van den Brandt PA; Goldbohm RA Cancer Causes Control; 1995 Sep; 6(5):416-24. PubMed ID: 8547539 [TBL] [Abstract][Full Text] [Related]
2. Combined effect of oral contraceptive use and hormone replacement therapy on breast cancer risk in postmenopausal women. Norman SA; Berlin JA; Weber AL; Strom BL; Daling JR; Weiss LK; Marchbanks PA; Bernstein L; Voigt LF; McDonald JA; Ursin G; Liff JM; Burkman RT; Malone KE; Simon MS; Folger SG; Deapen D; Wingo PA; Spirtas R Cancer Causes Control; 2003 Dec; 14(10):933-43. PubMed ID: 14750532 [TBL] [Abstract][Full Text] [Related]
3. Hormone replacement therapy and breast cancer in former users of oral contraceptives--The Norwegian Women and Cancer study. Lund E; Bakken K; Dumeaux V; Andersen V; Kumle M Int J Cancer; 2007 Aug; 121(3):645-8. PubMed ID: 17372914 [TBL] [Abstract][Full Text] [Related]
4. Hormone replacement therapy and risk of breast cancer with a favorable histology: results of the Iowa Women's Health Study. Gapstur SM; Morrow M; Sellers TA JAMA; 1999 Jun; 281(22):2091-7. PubMed ID: 10367819 [TBL] [Abstract][Full Text] [Related]
5. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones. Tworoger SS; Missmer SA; Barbieri RL; Willett WC; Colditz GA; Hankinson SE J Natl Cancer Inst; 2005 Apr; 97(8):595-602. PubMed ID: 15840882 [TBL] [Abstract][Full Text] [Related]
6. Sex steroid hormones and breast cancer: is there a link with oral contraceptives and hormone replacement therapy? Khoo SK; Chick P Med J Aust; 1992 Jan; 156(2):124-32. PubMed ID: 1736053 [TBL] [Abstract][Full Text] [Related]
7. Sex hormones and cardiovascular risk. La Vecchia C Hum Reprod; 1992 Feb; 7(2):162-7. PubMed ID: 1577926 [TBL] [Abstract][Full Text] [Related]
8. Female hormone utilisation and risk of hepatocellular carcinoma. Tavani A; Negri E; Parazzini F; Franceschi S; La Vecchia C Br J Cancer; 1993 Mar; 67(3):635-7. PubMed ID: 8382515 [TBL] [Abstract][Full Text] [Related]
9. Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer. Grabrick DM; Hartmann LC; Cerhan JR; Vierkant RA; Therneau TM; Vachon CM; Olson JE; Couch FJ; Anderson KE; Pankratz VS; Sellers TA JAMA; 2000 Oct; 284(14):1791-8. PubMed ID: 11025831 [TBL] [Abstract][Full Text] [Related]
10. Oral contraceptives, hormone replacement therapy and breast cancer risk: a cohort study of 16 928 women 48 years and older. Thorbjarnardottir T; Olafsdottir EJ; Valdimarsdottir UA; Olafsson O; Tryggvadottir L Acta Oncol; 2014 Jun; 53(6):752-8. PubMed ID: 24460068 [TBL] [Abstract][Full Text] [Related]
11. Oral contraceptives and breast cancer: a cooperative Italian study. La Vecchia C; Negri E; Franceschi S; Talamini R; Amadori D; Filiberti R; Conti E; Montella M; Veronesi A; Parazzini F Int J Cancer; 1995 Jan; 60(2):163-7. PubMed ID: 7829209 [TBL] [Abstract][Full Text] [Related]
12. Oral contraceptives and risk of breast cancer in women aged 20-54 years. Netherlands Oral Contraceptives and Breast Cancer Study Group. Rookus MA; van Leeuwen FE Lancet; 1994 Sep; 344(8926):844-51. PubMed ID: 7916400 [TBL] [Abstract][Full Text] [Related]
13. Type of postmenopausal hormone use and risk of breast cancer: 12-year follow-up from the Nurses' Health Study. Colditz GA; Stampfer MJ; Willett WC; Hunter DJ; Manson JE; Hennekens CH; Rosner BA; Speizer FE Cancer Causes Control; 1992 Sep; 3(5):433-9. PubMed ID: 1525324 [TBL] [Abstract][Full Text] [Related]
14. Oral contraceptives and breast cancer risk in Taiwan, a country of low incidence of breast cancer and low use of oral contraceptives. Chie WC; Li CY; Huang CS; Chang KJ; Yen ML; Lin RS Int J Cancer; 1998 Jul; 77(2):219-23. PubMed ID: 9650556 [TBL] [Abstract][Full Text] [Related]
15. Prospective study of exogenous hormones and risk of pulmonary embolism in women. Grodstein F; Stampfer MJ; Goldhaber SZ; Manson JE; Colditz GA; Speizer FE; Willett WC; Hennekens CH Lancet; 1996 Oct; 348(9033):983-7. PubMed ID: 8855854 [TBL] [Abstract][Full Text] [Related]
16. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. Colditz GA; Hankinson SE; Hunter DJ; Willett WC; Manson JE; Stampfer MJ; Hennekens C; Rosner B; Speizer FE N Engl J Med; 1995 Jun; 332(24):1589-93. PubMed ID: 7753136 [TBL] [Abstract][Full Text] [Related]
17. Use of oral contraceptives and breast cancer risk: The Norwegian-Swedish Women's Lifestyle and Health Cohort Study. Kumle M; Weiderpass E; Braaten T; Persson I; Adami HO; Lund E Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1375-81. PubMed ID: 12433714 [TBL] [Abstract][Full Text] [Related]
18. Previous oral contraceptive use and breast cancer risk according to hormone replacement therapy use among postmenopausal women. Dumeaux V; Fournier A; Lund E; Clavel-Chapelon F Cancer Causes Control; 2005 Jun; 16(5):537-44. PubMed ID: 15986108 [TBL] [Abstract][Full Text] [Related]
19. Breast cancer among young U.S. women in relation to oral contraceptive use. White E; Malone KE; Weiss NS; Daling JR J Natl Cancer Inst; 1994 Apr; 86(7):505-14. PubMed ID: 8133534 [TBL] [Abstract][Full Text] [Related]
20. Oral contraceptives and breast cancer. A prospective cohort study. Lipnick RJ; Buring JE; Hennekens CH; Rosner B; Willett W; Bain C; Stampfer MJ; Colditz GA; Peto R; Speizer FE JAMA; 1986 Jan; 255(1):58-61. PubMed ID: 3940306 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]